pleural empyema: The presence of pus in the thoracic cavity, between the visceral and parietal pleura. [database_cross_reference: NCIT:P378]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1519 |
4. Check minimum number of eventsNone |
1519 |
5. Include endpointsNone |
1519 |
6. Filter based on genotype QC (FinnGen only) |
1519 |
Control definitions (FinnGen only)
- Control exclude
- J10_NECROTIC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J85-J86
- Name in latin
- Empyema
Similar endpoints
↥List of similar endpoints to
Pyothorax
based on the number of shared cases.
Similar with more cases:
- Suppurative and necrotic conditions of lower respiratory tract
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13230 | 3541 | 9495 |
| Only index persons | 10093 | 2856 | 7237 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.22 | 0.10 | 0.27 |
| Only index persons | 0.23 | 0.10 | 0.28 |
| Median age at first event (years) | |||
| Whole population | 60.81 | 62.09 | 60.28 |
| Only index persons | 60.34 | 61.54 | 59.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1519 | 399 | 1120 |
| Unadjusted period prevalence (%) | 0.40 | 0.14 | 0.49 |
| Median age at first event (years) | 63.64 | 59.07 | 65.26 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1362
- Matched controls
- 13618
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J86.9
ICD-10 Finland
Pyothorax without fistula
+∞
323.0
1116
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.8
290.8
901
2476
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
45.3
279.1
345
101
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
13.8
214.3
397
394
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
+∞
202.2
189
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.0
168.1
576
1474
J01MA14
ATC
moxifloxacin; systemic
8.2
154.4
387
632
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
12.8
147.4
277
266
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
181.4
141.5
146
9
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
13.9
137.7
248
215
J01FF01
ATC
clindamycin; systemic
4.4
129.1
647
2335
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.3
125.9
380
782
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
103.5
871
4575
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.9
101.7
317
661
GD1AD
NOMESCO Finland
Thorax CT examination
8.8
94.5
215
283
GAC46
NOMESCO Finland
Partial decortication of pleura
204.0
92.6
95
5
J86.09
ICD-10 Finland
Pyothorax with fistula
+∞
90.6
86
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.5
88.2
294
654
ZXD05
NOMESCO Finland
Urgent procedure
3.2
82.6
636
2945
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
58.6
79.2
93
17
J01MA12
ATC
levofloxacin; systemic
3.4
74.5
452
1727
J94.8
ICD-10 Finland
Other specified pleural conditions
14.7
73.1
126
94
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
28.1
70.6
97
37
GAC96
NOMESCO Finland
Other operation on pleura
365.3
70.3
70
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
11.4
68.7
133
128
5100A
ICD-9 Finland
Empyema, With fistula
+∞
68.3
65
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
66.4
387
1414
TGA30
NOMESCO Finland
Thoracocentesis
25.3
63.7
90
38
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
53.8
272
872
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
53.3
265
837
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
51.0
283
972
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
+∞
50.3
48
*
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
473.2
46.6
46
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
30.3
45.6
61
21
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
43.1
475
2470
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
+∞
42.9
41
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
8.7
42.9
95
116
GAA97
NOMESCO Finland
Other thoracoscopic drainage procedures on pleura
147.8
41.0
43
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
40.2
173
476
WX892
NOMESCO Finland
Monitored bed care
3.5
39.0
201
643
R4110
NOMESCO Finland
Physiotherapy
2.3
37.1
441
2341
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
36.9
380
1878
C03CA01
ATC
furosemide; systemic
2.2
36.4
521
3009
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
36.3
174
523
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.2
34.6
138
352
JN4BD
NOMESCO Finland
Extensive body CT
2.9
34.6
241
949
J86
ICD-10 Finland
Pyothorax
+∞
34.5
33
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
33.8
231
896
R03BB04
ATC
tiotropium bromide; inhalant
2.9
33.7
229
886
GAA31
NOMESCO Finland
Thoracoscopy
30.2
33.1
44
15
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
32.8
165
515
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
14.6
30.8
52
37
R06.0
ICD-10 Finland
Dyspnoea
2.2
30.2
400
2190
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
12.8
29.7
53
43
WX872
NOMESCO Finland
Intensive care
3.7
29.6
138
404
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
29.2
291
1391
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
28.9
264
1205
N02AA05
ATC
oxycodone; systemic
2.4
26.8
267
1269
GDC00
NOMESCO Finland
Lobectomy of lung
19.1
25.7
39
21
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
25.4
658
4587
Z2446
NOMESCO Finland
Social worker
3.4
24.7
127
401
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
24.6
295
1528
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
24.6
523
3393
H02AB06
ATC
prednisolone; systemic
1.8
24.5
643
4481
N05BA01
ATC
diazepam; systemic, rectal
2.4
24.2
223
1017
GAC43
NOMESCO Finland
Total decortication of pleura
+∞
24.0
23
*
Z3226
NOMESCO Finland
Physiotherapist
2.2
23.6
296
1557
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
23.5
291
1523
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.5
23.4
115
351
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.4
23.2
118
369
N02AX02
ATC
tramadol; systemic, rectal
1.8
23.0
607
4211
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.7
22.9
67
123
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
4.6
22.4
80
183
B01AB05
ATC
enoxaparin; parenteral
1.9
22.0
433
2711
N05CF01
ATC
zopiclone; oral
1.8
22.0
470
3028
51009
ICD-8 Finland
Empyema, UD
+∞
21.9
21
*
N05AH02
ATC
clozapine; systemic
7.1
21.6
53
77
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
21.6
133
477
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.3
21.1
224
1088
Z2221
NOMESCO Finland
Medical doctor
1.9
21.1
386
2347
WX730
NOMESCO Finland
Conventional respirator
6.4
21.1
56
91
N05AA02
ATC
levomepromazine; systemic
3.7
21.0
95
271
GAC40
NOMESCO Finland
Pleurodesis with decortication
+∞
20.9
20
*
N05AH04
ATC
quetiapine; oral
2.2
20.7
234
1171
N05CD07
ATC
temazepam; oral
2.3
20.6
218
1056
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.7
20.3
91
258
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.9
20.0
130
483
A02BC02
ATC
pantoprazole; systemic
1.7
19.9
845
6654
J86.01
ICD-10 Finland
Empyema with pleuro-cutaneous fistula
+∞
19.8
19
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.5
19.6
51
81
R81
ICPC
Pneumonia
4.2
19.5
76
190
B18.2
ICD-10 Finland
Chronic viral hepatitis C
9.8
19.4
39
41
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
18.9
93
284
N03AX16
ATC
pregabalin; oral
1.9
18.9
323
1903
F10.25
ICD-10 Finland
Alcohol dependence continuous use
5.6
18.9
55
101
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
18.7
105
353
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
18.6
287
1628
R50.9
ICD-10 Finland
Fever, unspecified
2.1
18.3
224
1158
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
18.2
211
1063
R03AC02
ATC
salbutamol; inhalant
1.7
18.1
632
4650
N05AH03
ATC
olanzapine; systemic
3.1
18.0
102
345
ZXE00
NOMESCO Finland
One hour or less
1.7
17.9
528
3700
A41.9
ICD-10 Finland
Sepsis, unspecified
3.6
17.9
83
242
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
18.9
17.3
26
14
5862
FHL
Decortication (removal of visceral or parietal pleura)
42.6
17.3
21
5
N06AX11
ATC
mirtazapine; oral
1.8
17.2
405
2644
ZX120
NOMESCO Finland
Intravenous
2.4
17.0
155
696
GAW97
NOMESCO Finland
Other thoracoscopic operation on chest wall, pleura and diaphragm
50.7
17.0
20
*
Z3231
NOMESCO Finland
Registered nurse
1.8
16.7
394
2567
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
16.5
67
175
A28
ICPC
Limited function/disability NOS
2.0
16.4
237
1306
AA1AD
NOMESCO Finland
CT of head and brain
1.8
16.2
346
2187
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
6.2
16.1
43
71
N02BE01
ATC
paracetamol; systemic, rectal
1.8
16.1
1116
9770
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
16.1
106
397
WX250
NOMESCO Finland
Intercostal blockade
24.8
16.0
22
9
N05BA04
ATC
oxazepam; oral
1.8
16.0
322
1994
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
15.9
239
1333
J94.2
ICD-10 Finland
Haemothorax
13.1
15.7
27
21
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
15.6
397
2640
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
8.3
15.6
34
42
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
15.5
93
326
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
15.5
246
1401
TK800
NOMESCO Finland
Hemodialysis
4.4
15.4
56
132
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
15.3
73
219
R02
ICPC
Shortness of breath/dyspnoea
2.2
15.0
172
856
GAC00
NOMESCO Finland
Biopsy of pleura
14.1
15.0
25
18
WX725
NOMESCO Finland
Noninvasive ventilation
3.1
15.0
85
288
WX704
NOMESCO Finland
Intubation
2.6
14.9
116
477
A06AD11
ATC
lactulose; oral
1.9
14.9
229
1288
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
57.3
14.8
17
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
14.5
139
639
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
10.2
14.5
28
28
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.5
14.4
115
482
130
Kela drug reimbursment
Malignant tumour
2.2
14.3
150
720
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.8
14.3
61
167
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
14.2
175
901
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
14.2
153
743
WX110
NOMESCO Finland
Local anesthesy
1.6
14.0
828
6782
N03AG01
ATC
valproic acid; systemic, rectal
2.7
13.9
97
375
J47
ICD-10 Finland
Bronchiectasis
5.0
13.9
44
90
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
13.9
260
1561
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.6
13.9
35
54
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
17.7
13.8
21
12
JN4AD
NOMESCO Finland
Body CT examination
2.3
13.7
136
636
J96.0
ICD-10 Finland
Acute respiratory failure
5.8
13.6
38
67
WX882
NOMESCO Finland
High dependency care
3.6
13.6
61
174
N06AB03
ATC
fluoxetine; oral
2.1
13.6
158
795
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.8
13.5
56
150
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
13.5
227
1316
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.9
13.5
33
49
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
13.4
87
323
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
13.9
13.2
22
16
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
13.9
13.2
22
16
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
13.2
86
320
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.6
13.2
45
100
TGC00
NOMESCO Finland
Bronchial lavation
3.9
13.2
54
143
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
13.1
130
608
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
12.3
13.1
23
19
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
13.1
93
365
ZXA05
NOMESCO Finland
Left side
1.7
13.1
340
2254
N05BA02
ATC
chlordiazepoxide; systemic
3.8
13.1
55
149
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
13.1
100
410
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
6.2
12.9
34
56
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.1
12.9
70
232
GBB00
NOMESCO Finland
Tracheostomy
5.7
12.9
36
64
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
12.9
391
2705
N07BB01
ATC
disulfiram; oral
2.8
12.9
84
314
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
12.8
90
349
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.6
12.7
43
95
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
12.6
171
914
J94.9
ICD-10 Finland
Pleural condition, unspecified
8.3
12.6
27
33
51099
ICD-8 Finland
NA
+∞
12.5
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.0
12.4
71
243
B01AA03
ATC
warfarin; systemic
1.7
12.4
322
2129
J96.1
ICD-10 Finland
Chronic respiratory failure
3.7
12.3
53
147
J93.8
ICD-10 Finland
Other pneumothorax
10.6
12.3
23
22
S27.1
ICD-10 Finland
Traumatic haemothorax
7.8
12.1
27
35
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.2
12.1
45
110
WX402
NOMESCO Finland
General anaesthesia
1.9
12.0
203
1177
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.4
12.0
35
66
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.9
11.9
38
79
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
8.0
11.9
26
33
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
11.8
94
392
N06AA12
ATC
doxepin; systemic
2.7
11.7
82
321
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
7.8
11.6
26
34
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.0
11.6
66
224
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
19.1
11.6
17
9
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
8.2
11.6
25
31
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.5
11.5
53
156
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.4
11.4
33
62
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.3
357
2477
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.9
11.3
45
117
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.4
11.3
100
444
WW500
NOMESCO Finland
Blood transfusion
2.8
11.2
71
261
R4190
NOMESCO Finland
Nutritional therapy
3.3
11.1
55
171
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.7
11.0
76
294
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.0
10.9
29
49
N05AX08
ATC
risperidone; systemic
2.1
10.9
122
604
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
10.8
123
611
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
10.8
71
267
WX002
NOMESCO Finland
Sedation and analgesia
1.7
10.8
263
1702
C07AB07
ATC
bisoprolol; oral
1.5
10.7
645
5167
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
10.7
151
820
R03BB01
ATC
ipratropium bromide; inhalant
2.7
10.7
72
276
ZXA00
NOMESCO Finland
Right side
1.6
10.6
355
2493
A46
ICD-10 Finland
Erysipelas
1.8
10.6
203
1223
SPAT1255
SPAT
Intravenous administration of medicine
2.2
10.6
108
513
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
10.5
244
1559
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
110.8
10.4
11
*
P01AB01
ATC
metronidazole; oral, rectal
1.5
10.4
425
3131
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.1
10.4
55
181
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.2
10.3
31
61
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.0
10.2
40
103
Z51.5
ICD-10 Finland
Palliative care
2.3
10.2
95
430
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.5
10.1
45
130
R53
ICD-10 Finland
Malaise and fatigue
1.7
10.1
249
1616
C03DA01
ATC
spironolactone; oral
1.9
10.0
162
925
S22.4
ICD-10 Finland
Multiple fractures of ribs
3.6
10.0
43
121
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.9
9.9
31
64
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
9.9
200
1223
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
9.8
88
393
N06AB04
ATC
citalopram; systemic
1.6
9.8
251
1643
XG410
NOMESCO Finland
Flow-volume spirometry
2.6
9.8
69
270
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
9.8
107
524
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.1
9.8
52
172
N03AE01
ATC
clonazepam; systemic
2.4
9.7
82
357
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
9.6
87
392
K08.3
ICD-10 Finland
Retained dental root
2.1
9.6
106
523
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
4.1
9.6
36
90
J01DB01
ATC
cefalexin; oral
1.5
9.5
1013
8998
A03
ICPC
Fever
1.8
9.5
163
947
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.4
228
1472
J86.0
ICD-10 Finland
Pyothorax with fistula
+∞
9.4
9
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
12.4
9.4
16
13
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
21.8
9.4
13
6
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
7.0
9.3
22
32
F10.24
ICD-10 Finland
Alcohol depence active use
4.3
9.3
33
78
S42.0
ICD-10 Finland
Fracture of clavicle
3.2
9.2
47
151
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.8
9.2
29
61
R04.2
ICD-10 Finland
Haemoptysis
2.6
9.1
66
264
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
11.5
9.1
16
14
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
10.1
9.0
17
17
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
9.0
68
278
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.5
9.0
71
298
N05BA12
ATC
alprazolam; oral
2.0
9.0
122
652
WW200
NOMESCO Finland
Immunization
3.3
8.9
44
138
J01XX08
ATC
linezolid; systemic
7.5
8.9
20
27
R82
ICPC
Pleurisy/pleural effusion
24.2
8.9
12
5
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
5.0
8.8
27
55
J43.9
ICD-10 Finland
Emphysema, unspecified
3.7
8.8
36
98
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.9
8.7
52
186
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.4
8.7
40
119
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.7
455
3499
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.9
8.7
27
56
I50.0
ICD-10 Finland
Congestive heart failure
1.9
8.7
126
692
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
5.5
8.6
24
44
JN4CD
NOMESCO Finland
Very extensive body CT
2.5
8.6
63
255
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
8.6
74
324
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.0
8.6
49
169
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.3
8.5
40
122
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
20.2
8.5
12
6
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
8.5
547
4377
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
8.4
43
139
R03DA04
ATC
theophylline; systemic, rectal
2.2
8.4
84
397
J01MA02
ATC
ciprofloxacin; systemic
1.4
8.4
494
3882
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
8.4
83
388
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.5
8.4
28
63
S01.0
ICD-10 Finland
Open wound of scalp
1.9
8.4
114
612
R13
ICD-10 Finland
Dysphagia
2.1
8.4
90
437
W19
ICD-10 Finland
Unspecified fall
1.9
8.3
119
647
UJC12
NOMESCO Finland
Flexible oesophagoscopy
5.5
8.3
23
42
R95
ICPC
Chron obstructive pulmonary disease
2.8
8.2
50
182
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
14.6
8.2
13
9
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
8.2
67
288
S97
ICPC
Chronic ulcer skin
2.1
8.2
89
435
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
5.7
8.1
22
39
OAB43
SPAT
NA
0.4
8.1
34
813
C45.0
ICD-10 Finland
Mesothelioma of pleura
8.2
8.1
17
21
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.7
8.1
55
212
JAH00
NOMESCO Finland
Laparotomy
3.0
8.1
46
158
Z72.0
ICD-10 Finland
Tobacco use
3.3
8.1
38
116
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
11.8
8.1
14
12
K22.3
ICD-10 Finland
Perforation of oesophagus
17.3
8.1
12
7
RS221
NOMESCO Finland
NA
3.9
8.1
31
80
J01AA02
ATC
doxycycline; systemic
1.4
8.0
944
8374
SPAT1254
SPAT
Administration of medicine
1.7
8.0
188
1199
N07BA03
ATC
varenicline; oral
2.3
7.9
68
300
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.5
7.9
35
102
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.8
7.9
48
175
EBA00
NOMESCO Finland
Extraction of tooth
1.5
7.8
374
2815
J01CF05
ATC
flucloxacillin; systemic
2.6
7.8
57
229
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
7.8
99
517
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
7.7
186
1195
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
7.7
41
137
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.3
7.7
27
64
A41.8
ICD-10 Finland
Other specified sepsis
3.6
7.7
33
94
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.7
7.7
32
89
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
7.6
98
514
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
7.6
46
167
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.5
7.6
56
227
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
11.9
7.6
13
11
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
11.9
7.6
13
11
K86.1
ICD-10 Finland
Other chronic pancreatitis
5.5
7.5
21
39
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
4.7
7.5
24
52
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
7.4
123
706
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
7.4
375
2849
N05BA06
ATC
lorazepam; systemic, sublingual
2.2
7.4
74
348
J98.1
ICD-10 Finland
Pulmonary collapse
6.5
7.4
18
28
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.8
7.4
29
77
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.5
7.3
32
93
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
10.9
7.3
13
12
GDW97
NOMESCO Finland
Other thoracoscopic operation on lung
+∞
7.3
7
*
5842
FHL
Operative thoracostomy
+∞
7.3
7
*
XGX10
NOMESCO Finland
Intrapleural ultrasonography
+∞
7.3
7
*
J86.02
ICD-10 Finland
Empyema with broncho-pleural-cutaneous fistula
+∞
7.3
7
*
51010
ICD-8 Finland
NA
+∞
7.3
7
*
GAA15
NOMESCO Finland
Insertion of pleural drainage tube by resection of rib
+∞
7.3
7
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
9.4
7.3
14
15
SPAT1262
SPAT
Handing over of treatment supplies
1.5
7.3
239
1659
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
3.8
7.3
29
78
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
15.8
7.2
11
7
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.2
161
1015
N05AB01
ATC
dixyrazine; systemic
4.1
7.2
26
64
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.9
7.1
41
143
GDB10
NOMESCO Finland
Wedge resection of lung
12.1
7.1
12
10
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
6.1
7.1
18
30
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.9
7.1
27
70
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
7.1
28
75
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
7.0
87
449
P16
ICPC
Acute alcohol abuse
3.5
7.0
30
86
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
7.0
126
744
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.1
7.0
36
119
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.9
7.0
40
140
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.9
6.9
18
31
1240
FHL
Bronchoscopy
4.1
6.9
25
62
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.7
6.9
28
77
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.2
6.9
34
109
XG466
NOMESCO Finland
Sleep oxymetry
2.5
6.9
52
216
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.8
6.9
41
149
N03AX09
ATC
lamotrigine; oral
2.5
6.8
49
198
P18
ICPC
Medication abuse
8.3
6.8
14
17
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
4.2
6.8
24
58
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
9.4
6.8
13
14
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
4.5
6.8
22
49
P72
ICPC
Schizophrenia
3.8
6.8
27
73
P19
ICPC
Drug abuse
5.7
6.8
18
32
GAB96
NOMESCO Finland
Other thoracotomy
40.2
6.8
8
*
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
40.2
6.8
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
6.7
83
430
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.7
6.7
21
45
N05AF05
ATC
zuclopenthixol; systemic
4.7
6.7
21
45
N05AC02
ATC
thioridazine; oral
3.3
6.7
32
100
R84
ICPC
Malignant neoplasm bronchus/lung
7.2
6.7
15
21
N04AA02
ATC
biperiden; systemic
3.2
6.7
33
106
K92.0
ICD-10 Finland
Haematemesis
2.7
6.7
41
152
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.4
6.6
53
225
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.5
6.6
18
33
J93.9
ICD-10 Finland
Pneumothorax, unspecified
5.9
6.6
17
29
P15
ICPC
Chronic alcohol abuse
2.5
6.6
47
189
N05AF03
ATC
chlorprothixene; systemic
2.7
6.6
43
164
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
4.1
6.6
24
60
N06AB06
ATC
sertraline; oral
1.8
6.6
103
581
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
6.6
62
288
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
6.6
131
800
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
6.6
82
428
N06AX16
ATC
venlafaxine; oral
1.7
6.6
129
784
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.8
6.5
40
148
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
10.1
6.5
12
12
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
70.1
6.4
7
*
J15.2
ICD-10 Finland
Pneumonia due to staphylococcus
70.1
6.4
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.2
6.4
60
276
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
6.4
119
708
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
14.4
6.4
10
7
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.9
6.4
19
39
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
6.4
78
404
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
6.3
94
523
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.2
6.3
22
53
V03AA01
ATC
NA
3.0
6.3
33
111
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
4.6
6.3
20
44
188
Kela drug reimbursment
Psychosis requiring demanding treatment
4.3
6.2
21
49
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
6.2
102
585
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
7.1
6.2
14
20
R4120
NOMESCO Finland
Occupational therapy
1.9
6.2
81
429
H02AB02
ATC
dexamethasone; systemic
1.7
6.2
124
757
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.3
6.2
29
90
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.8
6.2
24
64
X57
ICD-10 Finland
Unspecified privation
2.8
6.1
37
136
K22.2
ICD-10 Finland
Oesophageal obstruction
4.2
6.1
21
50
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
7.7
6.1
13
17
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
3.2
6.1
29
91
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.7
6.1
123
752
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.6
6.1
40
154
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.1
172
1149
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
6.1
305
2304
C09AA05
ATC
ramipril; oral
1.4
6.1
326
2492
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
4.4
6.0
20
46
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.2
6.0
29
92
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
6.0
58
273
R03AC12
ATC
salmeterol; inhalant
2.2
6.0
55
252
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
233
112
24.39
316.28
1.4
1.3
u/l
26.7
12.5
4.59
218
103
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
324
297
13.60
315.05
1.8
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
210
82
29.56
308.22
1.4
1.5
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
288
141
24.97
307.65
1.4
1.4
u/l
1935.5
326.0
5.12
271
136
(3003434) Protein [Mass/volume] in Pleural fluid
377
213
23.21
307.65
1.6
1.5
g/l
37.1
31.2
7.92
351
189
(3028308) Erythrocytes [#/volume] in Pleural fluid
333
169
24.96
307.65
1.6
1.4
e6/l
46651.6
79933.1
0.60
212
98
(40768806) Pleura Pathology biopsy report
292
173
20.66
307.65
1.7
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
295
147
24.66
307.65
1.7
1.5
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
303
148
25.33
307.65
1.5
1.4
mmol/l
4.3
6.4
11.82
250
142
(3012441) Differential panel - Pleural fluid
314
168
23.30
307.65
1.7
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
357
191
24.13
307.65
1.6
1.5
e6/l
17027.1
1523.4
3.91
259
134
(3042936) Bacteria identified in Isolate by Culture
711
1874
6.25
273.52
2.9
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
329
379
10.80
272.02
1.8
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
361
496
9.24
259.71
3.1
2.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
190
102
21.15
244.81
1.6
1.4
u/l
11.5
14.0
3.01
182
96
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
260
268
11.50
231.48
1.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
903
3791
4.41
177.76
7.6
4.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
409
1086
4.79
144.93
2.7
2.7
g/l
61.8
66.5
21.45
387
986
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
461
1535
3.88
117.87
3.3
4.0
u/l
220.0
242.7
4.41
446
1451
(3023383) Lactate [Moles/volume] in Pleural fluid
86
50
18.17
105.63
1.6
1.5
mmol/l
6.8
3.4
5.09
74
43
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
542
2185
3.30
100.68
2.5
1.9
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
87
67
13.71
91.92
1.6
1.4
%
34.4
66.1
6.23
77
49
(3000494) Fungus identified in Specimen by Culture
401
1419
3.48
90.91
2.0
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
416
1517
3.40
89.77
2.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
411
1518
3.34
86.53
2.3
1.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
237
604
4.46
85.66
2.9
1.9
ug/l
1.9
1.9
0.02
218
526
(42870588) Differential panel, method unspecified - Blood
754
4029
2.73
79.54
9.5
5.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
408
1575
3.17
79.00
13.4
8.0
kpa
5.4
5.1
4.73
390
1499
(3027801) Oxygen [Partial pressure] in Arterial blood
408
1576
3.17
78.91
13.4
8.0
kpa
10.6
11.9
7.89
391
1502
(3001893) Eosinophils/100 leukocytes in Pleural fluid
72
53
14.21
77.96
1.6
1.5
%
2.1
1.2
0.82
66
44
(3000919) Neutrophils/100 leukocytes in Pleural fluid
70
49
14.93
77.95
1.4
1.4
%
57.7
25.0
6.53
62
44
(3003396) Base excess in Arterial blood by calculation
405
1573
3.15
77.43
13.5
8.0
mmol/l
2.3
1.1
6.47
353
1223
(3022096) Basophils/100 leukocytes in Blood
890
5302
2.64
73.27
9.8
6.0
%
0.5
0.7
8.32
862
4952
(3012095) Magnesium [Moles/volume] in Serum or Plasma
475
2074
2.88
73.05
5.0
3.4
mmol/l
0.8
0.8
4.65
449
1940
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
64
43
15.49
72.82
1.3
1.3
ug/l
236.7
69.3
0.84
42
23
(3019069) Monocytes/100 leukocytes in Blood
908
5474
2.64
72.73
10.3
6.3
%
9.0
9.0
0.05
879
5125
(3001604) Monocytes [#/volume] in Blood
940
5778
2.64
72.06
9.3
5.8
e9/l
0.7
0.6
18.14
817
4963
(3006315) Basophils [#/volume] in Blood
941
5802
2.63
71.42
9.3
5.8
e9/l
0.0
0.0
1.44
823
4996
(3006504) Eosinophils/100 leukocytes in Blood
901
5450
2.61
71.04
9.9
6.0
%
2.6
2.9
3.52
873
5078
(3019060) Gas panel - Arterial blood
282
929
3.50
70.08
9.5
5.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
994
6335
2.65
69.73
9.7
6.5
umol/l
10.6
12.3
7.22
967
6020
(3002030) Lymphocytes/100 leukocytes in Blood
911
5582
2.58
69.22
10.2
6.1
%
21.1
26.6
39.78
882
5208
(3014111) Lactate [Moles/volume] in Serum or Plasma
322
1160
3.25
69.21
11.0
7.5
mmol/l
1.3
1.5
1.62
308
1115
(3019198) Lymphocytes [#/volume] in Blood
948
5920
2.60
69.17
9.8
5.9
e9/l
1.7
1.9
2.29
835
5201
(3013115) Eosinophils [#/volume] in Blood
954
5990
2.59
68.57
10.5
6.0
e9/l
0.2
0.2
0.30
843
5255
(3018010) Neutrophils/100 leukocytes in Blood
899
5494
2.56
68.37
9.6
5.9
%
63.2
58.1
26.37
868
5146
(3024561) Albumin [Mass/volume] in Serum or Plasma
861
5272
2.46
63.45
8.0
5.2
g/l
30.6
35.0
53.40
817
4901
(3020779) Urea [Moles/volume] in Serum or Plasma
328
1259
3.05
62.74
8.9
7.8
mmol/l
10.5
10.7
0.10
314
1193
(3016502) Oxygen saturation in Arterial blood
356
1434
2.94
62.42
14.5
8.2
%
94.4
95.4
1.65
346
1378
(3042631) Mycobacterium sp identified in Specimen
113
198
6.09
62.40
3.4
3.0
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
50
29
17.79
61.16
1.6
1.3
mmol/l
1.7
1.5
0.19
40
21
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
93
137
7.17
60.69
3.8
4.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1009
6735
2.48
59.95
16.7
9.1
e9/l
5.4
4.3
21.32
902
5862
(3003458) Phosphate [Moles/volume] in Serum or Plasma
393
1716
2.74
58.78
8.6
6.4
mmol/l
1.1
1.0
2.32
374
1588
(46235355) HIV 1 and 2 tests - Meaningful Use set
363
1523
2.82
58.63
1.9
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
263
927
3.22
57.92
2.1
1.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
57
47
12.56
57.57
1.6
1.4
%
52.9
24.3
3.91
42
35
(3023419) Bacteria identified in Sputum by Culture
104
183
6.03
57.12
3.9
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
180
505
3.91
56.27
3.2
2.7
u/ml
0.3
0.3
0.53
88
290
(3002173) Hemoglobin [Mass/volume] in Arterial blood
323
1305
2.87
55.75
15.7
8.8
g/l
115.1
122.5
8.02
314
1251
(3032080) INR in Blood by Coagulation assay
855
5414
2.33
55.63
13.3
10.7
inr
1.4
1.3
0.28
241
1509
(3033658) Prothrombin time (PT) actual/Normal
577
3102
2.39
54.95
7.3
4.1
%
82.3
85.5
2.56
563
3034
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
861
5512
2.30
53.97
13.0
6.4
mmol/l
1.2
1.2
9.95
817
4970
(3000991) Gas panel - Venous blood
287
1120
2.93
52.57
12.9
8.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
424
2056
2.47
50.07
2.3
2.0
s
30.7
30.1
1.31
412
1993
(40758558) Short blood count panel - Blood
539
2917
2.31
49.50
10.3
6.7
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
42
28
15.40
47.80
1.7
1.3
mmol/l
0.5
1.4
0.83
34
20
(44786800) Granulocytes/100 leukocytes in Body fluid
37
19
19.93
47.71
1.7
1.6
%
48.8
18.1
2.62
30
13
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
894
6027
2.17
46.54
13.9
7.2
mmol/l
1.2
1.2
9.33
772
5063
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
39
24
16.65
46.22
1.7
1.3
u/l
60.1
16.4
0.80
31
18
(3002032) Base excess in Venous blood by calculation
295
1254
2.68
45.41
5.4
3.7
mmol/l
2.1
2.0
0.07
243
981
(3021447) Carbon dioxide [Partial pressure] in Venous blood
295
1255
2.68
45.33
5.5
3.7
kpa
6.0
5.9
1.57
280
1216
(3014891) Appearance of Pleural fluid
40
28
14.65
44.32
2.0
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
602
3555
2.15
43.31
6.6
4.3
ph
7.4
7.4
0.88
125
700
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
66
97
7.07
43.06
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
276
1170
2.66
42.51
2.7
2.3
g/l
0.2
0.2
4.56
253
1087
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
619
3760
2.09
40.73
3.4
2.6
u/l
54.3
58.0
0.81
589
3486
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
196
709
3.03
40.58
14.5
10.4
mmol/l
25.4
24.3
3.59
183
667
(3013826) Glucose [Moles/volume] in Serum or Plasma
1008
7342
2.11
40.04
10.6
5.1
mmol/l
7.0
6.9
1.23
980
6928
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
178
624
3.10
38.87
5.2
4.0
mmol/l
24.3
24.1
0.40
162
564
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
621
3826
2.05
38.86
4.6
3.4
u/l
68.4
35.8
0.68
587
3637
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
453
2480
2.18
38.76
5.1
4.0
ng/l
588.6
854.4
0.26
388
2066
(3008152) Bicarbonate [Moles/volume] in Arterial blood
220
884
2.74
37.38
16.3
7.4
mmol/l
25.9
24.5
5.96
208
819
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
96
229
4.41
37.08
1.8
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
350
1773
2.27
35.93
3.2
2.7
%
19.0
23.1
5.61
296
1520
(1616796) Gas panel - Central venous blood
115
321
3.79
35.88
6.6
4.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
193
740
2.84
35.79
15.6
11.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
365
1884
2.23
35.78
3.1
2.6
g/l
2.1
2.3
5.95
343
1750
(3022948) Iron [Moles/volume] in Serum or Plasma
384
2025
2.20
35.69
3.2
2.7
umol/l
9.4
13.0
20.64
359
1879
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
173
634
2.95
34.82
1.6
1.9
g/l
1.8
1.5
2.44
147
548
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
86
198
4.54
34.72
9.3
6.7
mg/l
11.6
11.6
0.03
81
184
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
526
3156
2.02
34.51
2.6
2.2
mg/l
3.2
3.0
0.59
459
2689
(3021589) Normoblasts [#/volume] in Blood
757
5149
1.94
34.37
17.1
10.1
e9/l
0.0
0.0
0.13
601
4185
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
87
205
4.44
34.11
1.8
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
303
1479
2.31
33.77
2.2
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
81
182
4.64
33.69
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
113
326
3.66
33.58
1.9
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
234
1023
2.52
33.32
4.8
2.9
kpa
5.0
4.5
1.59
225
989
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
109
313
3.67
32.60
1.9
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
204
859
2.59
31.32
17.9
9.7
%
0.7
0.7
0.24
204
853
(3027945) Reticulocytes/100 erythrocytes in Blood
307
1554
2.22
31.13
3.1
2.5
%
2.0
1.8
2.31
282
1380
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
204
864
2.57
30.93
17.8
9.5
%
1.5
1.3
1.26
204
858
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
29
22
13.42
30.60
1.8
1.8
%
2.5
4.5
0.56
15
11
(3005719) IgG [Mass/volume] in Serum or Plasma
209
903
2.52
30.37
3.6
2.7
g/l
10.7
10.8
0.04
193
827
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1149
9185
2.03
30.29
13.4
7.8
u/l
90.3
79.8
9.18
1118
8640
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
189
782
2.62
30.02
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
100
288
3.65
29.76
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
100
288
3.65
29.76
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
594
3876
1.87
29.26
4.0
3.4
e6/l
61.5
100.8
0.88
456
3057
(3037756) Immunofixation for Serum or Plasma
96
274
3.67
28.95
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
589
3846
1.87
28.85
3.9
2.5
—
—
—
0
0
(3026782) Osmolality of Urine
431
2547
1.97
28.56
3.1
2.9
mosm/kgh2o
533.5
570.1
3.03
381
2165
(36304419) Bacteria [Presence] in Urine
535
3399
1.89
28.48
3.7
3.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
26
19
13.91
27.98
1.0
1.2
u/l
15.7
25.9
0.61
20
13
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
670
4601
1.82
27.52
3.9
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
186
4.19
27.51
1.9
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
273
1382
2.19
27.39
2.9
2.8
umol/l
7.8
9.6
0.95
234
1236
(3030467) Casts [#/volume] in Urine by Automated count
545
3524
1.85
27.16
3.7
3.3
e6/l
0.9
0.5
0.58
413
2717
(3012501) Base excess in Blood by calculation
103
321
3.37
27.15
9.2
5.1
mmol/l
3.1
2.4
1.36
85
216
(3013290) Carbon dioxide [Partial pressure] in Blood
103
322
3.36
27.01
9.3
5.1
kpa
5.4
5.0
2.42
98
316
(3027315) Oxygen [Partial pressure] in Blood
103
322
3.36
27.01
9.3
5.1
kpa
8.3
8.5
0.53
98
315
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
189
4.12
26.93
2.1
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
170
709
2.57
26.46
2.3
1.7
g/l
1.4
1.4
0.02
155
651
(3006184) Hemoglobin [Mass/volume] in Capillary blood
94
285
3.45
25.86
2.6
2.3
g/l
124.8
130.4
1.22
68
217
(3010421) pH of Blood
111
374
3.12
25.74
9.0
4.8
ph
7.4
7.4
0.01
99
315
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
229
1112
2.25
25.33
3.4
2.4
u/l
41.6
38.1
0.15
202
958
(3020891) Body temperature
141
549
2.73
25.15
11.2
4.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
233
1151
2.21
24.68
3.6
3.0
ng/l
270.9
236.4
0.48
214
1044
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
81
232
3.63
24.29
2.0
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
110
383
3.02
24.09
3.8
3.2
mmol/l
24.7
25.0
0.27
93
327
(3018095) Leukocytes [#/volume] in Urine
631
4381
1.75
24.01
4.7
3.8
e6/l
104.7
130.3
0.30
471
3258
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
766
5618
1.73
23.94
5.8
4.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
407
2495
1.86
23.41
2.0
1.7
mg/l
1.6
1.4
0.93
347
1940
(3017181) Myelocytes/100 leukocytes in Blood
206
998
2.23
22.80
4.8
4.3
%
1.1
0.8
1.05
103
330
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
184
851
2.32
22.74
5.7
3.7
mmol/l
2.3
1.8
0.71
136
636
(3026008) Bacteria identified in Urine by Culture
496
3264
1.77
22.39
3.6
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
459
2964
1.79
22.05
3.6
2.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
966
7663
1.72
21.73
5.7
4.4
e6/l
7165.1
1796.9
0.33
14
135
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
190
908
2.25
21.69
5.9
3.7
kpa
5.1
5.2
0.16
179
842
(3009343) pH of Capillary blood
188
895
2.26
21.66
6.0
3.7
ph
7.4
7.4
0.91
37
110
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
175
815
2.30
21.23
2.3
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
84
272
3.21
20.80
3.3
2.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
223
1156
2.09
20.68
3.2
2.6
e9/l
73.2
69.6
0.63
164
890
(3036481) Cortisol [Moles/volume] in Serum or Plasma
201
1005
2.15
20.47
2.4
2.1
nmol/l
388.6
364.8
0.87
190
920
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
248
1342
2.01
20.44
5.9
3.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
88
297
3.08
20.33
3.4
2.6
%
15.7
16.2
0.51
49
151
(3017143) Hepatitis C virus Ab [Presence] in Serum
219
1139
2.08
20.10
1.9
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
92
324
2.96
19.74
3.9
3.0
kpa
7.8
7.9
0.17
86
294
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
67
195
3.55
19.63
1.2
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
421
2731
1.75
19.50
3.2
2.7
e6/l
5.7
4.1
1.41
383
2409
(3021879) Hepatitis B virus core Ab [Presence] in Serum
156
718
2.31
19.41
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
233
1257
2.01
19.30
1.8
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
47
107
4.50
19.25
2.0
1.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
110
432
2.67
19.24
12.6
7.3
mmol/l
1.3
1.4
0.49
97
373
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
38
73
5.31
18.96
2.3
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
38
73
5.31
18.96
4.8
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
560
3951
1.66
18.87
4.7
3.4
mmol/l
2.3
2.3
1.91
507
3431
(3004119) Hemoglobin [Mass/volume] in Venous blood
169
818
2.20
18.61
5.9
3.3
g/l
121.1
128.8
3.54
162
801
(3002179) Metamyelocytes/100 leukocytes in Blood
180
902
2.13
18.14
4.6
4.1
%
0.6
0.6
0.13
76
237
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
36
69
5.32
18.01
1.6
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
551
3907
1.64
18.00
3.9
3.2
ng/l
2128.3
1762.9
0.98
496
3377
(3004588) Protein electrophoresis panel - Serum or Plasma
179
898
2.13
17.99
3.3
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
54
144
3.85
17.97
2.2
1.8
—
—
—
0
0
(3039000) Anion gap in Blood
87
313
2.89
17.97
13.8
8.2
mmol/l
10.6
11.5
1.52
79
274
(3018572) Chloride [Moles/volume] in Blood
87
313
2.89
17.97
13.8
8.2
mmol/l
104.5
105.7
1.45
79
274
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
73
5.17
17.93
2.4
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
85
4.81
17.81
2.3
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
85
304
2.90
17.74
1.4
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
93
350
2.77
17.66
3.0
2.3
g/l
4.2
3.7
1.29
88
327
(40760888) Immunoglobulin light chains.free panel - Serum
90
333
2.81
17.65
3.8
3.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
490
2.48
17.46
3.0
2.5
g/l
4.0
3.9
0.30
79
357
(4198724)
25
34
7.46
17.41
1.6
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
491
2.48
17.38
3.0
2.5
g/l
8.1
7.3
2.67
79
372
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
491
2.48
17.38
3.0
2.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
108
443
2.55
17.29
4.1
3.4
mg/l
42.6
78.4
0.61
89
354
(3034860) Kappa light chains.free [Mass/volume] in Serum
108
443
2.55
17.29
4.2
3.4
mg/l
75.8
67.5
0.16
90
352
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
232
1300
1.93
17.10
3.0
4.3
ug/l
10.5
23.2
0.95
199
1089
(3023183) Ammonium ion [Moles/volume] in Plasma
88
328
2.79
17.03
3.1
2.9
umol/l
44.2
33.6
0.51
76
274
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
105
432
2.54
16.71
4.1
3.4
ratio
1.3
1.6
—
7
41
(4062490)
43
104
4.23
16.34
1.4
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
108
456
2.47
16.27
3.1
2.5
g/l
10.5
10.6
0.03
88
385
(44806118)
53
151
3.60
16.06
1.6
1.6
—
—
—
0
0
(44790049)
53
151
3.60
16.06
1.6
1.6
—
—
—
0
0
(44790047)
53
151
3.60
16.06
1.6
1.6
—
—
—
0
0
(44790048)
53
151
3.60
16.06
1.6
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
632
4745
1.57
15.69
3.7
2.8
ug/l
218.3
164.2
2.89
597
4347
(3019309) Folate [Moles/volume] in Red Blood Cells
367
2414
1.69
15.67
2.1
1.8
nmol/l
1251.0
1160.6
0.93
302
1835
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
125
573
2.29
15.66
10.8
5.9
%
1.8
1.7
1.05
116
530
(3007930) Methemoglobin/Hemoglobin.total in Blood
123
562
2.29
15.53
11.0
6.0
%
0.9
0.9
0.64
115
520
(3021440) Promyelocytes/100 leukocytes in Blood
178
940
2.01
15.51
5.1
4.4
%
0.1
0.1
0.01
92
301
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
463
2.41
15.28
2.9
2.5
g/l
3.5
3.1
2.06
79
363
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
321
2050
1.72
15.24
3.5
3.1
e6/l
3.1
1.3
1.99
155
1187
(3037692) Legionella sp identified in Specimen by Organism specific culture
27
47
5.83
14.95
1.4
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
42
107
4.01
14.91
2.5
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
65
221
3.03
14.86
1.5
1.3
mmol/l
55.2
62.6
0.74
48
180
(3024928) Oxygen saturation in Venous blood
78
294
2.74
14.79
5.3
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
57
180
3.25
14.75
5.6
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
66
228
2.98
14.68
3.7
3.5
%
60.2
58.5
0.37
66
228
(3028707) Methadone [Presence] in Urine by Screen method
46
129
3.65
14.28
3.7
2.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
40
102
4.00
14.19
1.4
1.3
g/l
6.7
7.2
0.31
24
68
(3024139) IgG subclass 3 [Mass/volume] in Serum
40
102
4.00
14.19
1.4
1.3
g/l
0.3
0.4
1.61
24
67
(3028192) IgG subclass 2 [Mass/volume] in Serum
40
102
4.00
14.19
1.5
1.3
g/l
2.8
3.0
0.22
22
68
(3011412) CD3 cells [#/volume] in Blood
41
107
3.91
14.10
1.7
2.2
e9/l
1.0
1.0
0.15
26
59
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
520
3816
1.55
13.84
2.8
2.2
u/l
227.5
252.9
0.23
496
3583
(4035726)
182
1013
1.91
13.56
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
62
218
2.92
13.38
4.3
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
327
2167
1.65
13.31
3.3
2.9
e6/l
1.5
0.9
1.24
159
1299
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1007
11419
0.65
13.29
4.4
4.5
mmol/l
1.3
1.4
2.25
917
10453
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
33
78
4.30
12.94
1.5
2.2
%
19.4
16.7
0.27
14
33
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
96
428
2.33
12.83
3.1
2.6
g/l
0.3
1.4
3.58
80
371
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
331
2219
1.63
12.82
3.9
3.2
mmol/l
2.5
2.4
7.43
282
1942
(3027273) Bicarbonate [Moles/volume] in Venous blood
131
665
2.06
12.69
5.1
3.4
mmol/l
25.8
25.1
1.16
126
644
(3025159) Blasts/100 leukocytes in Blood
161
881
1.93
12.60
5.4
4.4
%
0.0
0.1
1.69
77
254
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
78
320
2.52
12.51
2.3
1.3
g/l
0.2
0.2
0.06
70
307
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
314
2.53
12.51
1.3
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
55
188
3.00
12.49
6.8
5.1
umol/l
372.2
354.7
0.38
47
169
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
94
3.90
12.39
2.9
1.5
promille
1.4
1.3
0.16
27
72
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
158
869
1.91
12.18
5.1
4.3
ng/l
110.1
100.9
0.42
146
763
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1025
11517
0.66
12.01
4.5
4.6
mmol/l
4.3
4.5
9.56
939
10628
(3024980) IgG subclass 4 [Mass/volume] in Serum
51
171
3.05
11.98
1.6
1.8
g/l
0.8
0.9
0.30
31
130
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
44
138
3.25
11.56
1.5
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
78
333
2.42
11.51
2.4
1.3
g/l
1.1
1.2
1.34
69
322
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
38
109
3.55
11.45
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
274
3982
0.62
11.42
3.0
3.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
65
256
2.61
11.36
5.1
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
42
131
3.27
11.14
1.5
2.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
16
8.82
11.12
1.1
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
84
379
2.29
10.95
2.7
2.5
g/l
0.0
0.0
1.03
79
346
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
66
267
2.54
10.93
6.6
5.7
iu/ml
195.4
873.2
0.80
16
41
(3000764) Benzodiazepines [Presence] in Urine
67
274
2.51
10.85
5.1
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
67
276
2.49
10.69
4.9
1.9
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
57
218
2.68
10.57
3.1
3.8
%
1.6
1.3
0.23
51
172
(3028300) Cannabinoids [Presence] in Urine
67
278
2.48
10.53
5.5
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
985
11068
0.69
10.43
4.2
4.1
mmol/l
1.4
1.3
0.59
884
10072
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1062
11763
0.68
10.35
4.9
5.1
mmol/l
2.4
2.7
11.35
962
10767
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
635
5069
1.43
10.33
2.4
2.0
pmol/l
87.6
93.2
2.64
401
2770
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
101
506
2.07
10.15
2.1
1.8
u/l
36.5
38.0
0.38
90
442
(3022217) INR in Platelet poor plasma by Coagulation assay
272
1832
1.59
10.12
24.1
27.7
inr
1.6
1.4
0.75
36
253
(3037522) Nuclear Ab [Titer] in Serum
217
1385
1.66
10.03
1.5
1.3
titre
488.4
437.0
0.23
38
295
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
81
374
2.23
10.01
1.4
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
78
355
2.26
9.98
2.8
2.5
g/l
0.0
0.0
0.00
73
326
(3027944) Amphetamines [Presence] in Urine
65
274
2.43
9.89
5.3
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
78
359
2.24
9.72
2.8
2.5
g/l
0.0
0.0
0.00
73
326
(3007164) IgA [Mass/volume] in Serum or Plasma
286
1970
1.56
9.62
1.8
1.4
g/l
3.0
2.7
1.04
192
1224
(40760892) CBC W Ordered Manual Differential panel - Blood
344
2468
1.51
9.58
7.1
4.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
37
118
3.19
9.50
1.3
1.2
u/ml
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
398
2947
1.47
9.48
1.9
1.6
nmol/l
18.4
19.9
1.37
369
2518
(3022313) Gas panel - Capillary blood
119
648
1.91
9.45
6.9
3.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
984
8569
1.42
9.40
6.0
4.0
mm/h
26.6
12.5
45.71
932
7881
(3036489) Thrombin time
89
438
2.10
9.39
2.2
1.9
s
22.1
21.8
0.22
81
395
(3000093) Morphology [Interpretation] in Blood Narrative
35
111
3.20
9.08
1.1
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
82
398
2.12
8.97
2.7
2.4
g/l
34.4
37.4
3.87
73
339
(3052851) Hemolysis interference index of Serum or Plasma
77
366
2.16
8.89
5.2
3.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
28
78
3.64
8.85
1.8
2.3
e6/l
564.3
624.7
0.16
20
69
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
98
512
1.98
8.79
2.2
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
929
8055
1.39
8.79
5.6
4.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
37
124
3.03
8.77
1.4
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
37
124
3.03
8.77
1.4
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
37
124
3.03
8.77
1.4
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
284
3910
0.66
8.72
2.8
3.1
ug/l
0.7
0.8
0.55
199
2617
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
558
4454
1.40
8.66
2.7
2.2
nmol/l
72.3
76.3
2.42
505
3919
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
422
5387
0.70
8.62
3.8
4.3
%
22.2
21.7
0.20
193
2660
(3052592) Norovirus Ag [Presence] in Stool
14
22
6.41
8.53
1.5
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
77
3.55
8.26
1.3
1.3
u/ml
0.3
0.2
0.18
19
43
(3005322) IgE [Units/volume] in Serum or Plasma
110
613
1.86
8.15
1.4
1.3
u/ml
159.0
268.8
1.30
101
568
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
190
1235
1.62
8.12
2.7
2.5
ug/l
7.7
7.7
0.02
168
1104
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
31
5.21
7.93
1.7
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
886
0.38
7.89
1.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
604
4943
1.37
7.85
5.1
3.9
ng/l
37.5
65.0
1.82
503
3688
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
101
561
1.86
7.57
2.5
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
48
201
2.43
7.48
1.1
1.2
—
—
—
0
0
(4010399)
139
853
1.69
7.43
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
558
6699
0.74
7.41
4.5
5.0
ug/l
2.6
3.2
0.42
493
5992
(3008757) Leukocyte morphology finding [Identifier] in Blood
40
154
2.64
7.40
3.9
4.7
—
—
—
0
0
(3017704) Immunofixation for Urine
26
81
3.25
6.99
1.3
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
24
71
3.42
6.98
2.7
3.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
25
76
3.33
6.98
1.6
2.4
e9/l
0.3
0.2
0.41
19
69
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
31
4.88
6.93
1.4
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
17
40
4.29
6.76
1.2
2.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
16
36
4.48
6.71
1.6
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1051
9485
1.35
6.62
44.7
19.3
%
14.6
13.8
45.26
1036
9267
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
65
326
2.04
6.59
1.4
1.6
iu/ml
1.7
22.1
0.51
21
61
(21494890) Protein electrophoresis panel - 24 hour Urine
36
140
2.61
6.56
2.8
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
36
140
2.61
6.56
2.5
2.6
—
—
—
0
0
(3000012) Reticulocyte production index
21
61
3.48
6.29
1.4
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
19
5.82
6.11
15.5
7.8
mmol/l
4.6
6.5
1.78
11
19
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
204
1437
1.48
6.04
2.4
1.9
%
1.9
1.6
3.63
171
1225
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
29
106
2.77
5.97
1.7
1.2
u/l
118.5
54.1
0.63
17
74
(3015736) pH of Urine
527
4369
1.32
5.83
4.3
3.3
—
5.8
—
0
5
(3051651) Icteric interference index of Serum or Plasma
24
80
3.03
5.81
4.7
3.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
57
287
2.02
5.76
2.8
3.1
nmol/l
0.8
0.9
0.36
40
219
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
19
56
3.42
5.59
2.4
2.4
u/ml
1017.6
1188.6
0.15
19
56
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
61
3.31
5.59
1.9
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
27
99
2.76
5.54
2.4
1.9
%
9.4
11.3
1.20
27
99
(21494814) CD8 cells/100 lymphocytes in Specimen
16
42
3.84
5.54
1.6
1.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
21
5.27
5.53
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
83
483
1.76
5.41
2.7
3.5
u/ml
307.5
8469.2
0.80
66
409
(3051611) Lipemic interference index of Serum or Plasma
30
119
2.55
5.31
4.4
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
210
1527
1.44
5.27
1.4
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
33
139
2.40
5.16
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
29
115
2.55
5.14
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1244
11667
1.37
5.13
41.2
16.0
mg/l
50.7
26.9
59.53
1181
9428
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
62
337
1.88
5.06
1.8
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
49
916
0.52
4.99
1.3
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
533
4509
1.28
4.86
2.4
2.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
24
89
2.72
4.85
2.5
2.9
%
34.9
37.9
0.30
12
32
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
137
2.36
4.85
2.5
3.9
%
65.8
54.3
2.34
26
95
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
96
1484
0.62
4.84
4.0
4.6
%
32.0
32.0
0.02
68
997
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
37
170
2.21
4.77
1.8
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
329
2617
1.33
4.74
4.3
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
569
0.41
4.72
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
184
2.15
4.72
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
850
7621
1.26
4.72
4.7
3.2
u/l
76.3
55.2
5.17
792
7087
(40757373) Influenza virus identified in Isolate
13
33
3.96
4.71
1.5
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
63
3.04
4.68
1.9
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
31
134
2.34
4.61
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
932
8473
1.26
4.48
5.1
4.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
21
76
2.79
4.46
3.3
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1062
11358
0.78
4.39
4.9
4.7
mmol/l
6.2
6.1
1.73
958
10297
(3040151) Glucose [Moles/volume] in Capillary blood
33
150
2.23
4.39
3.3
7.9
mmol/l
7.9
7.1
0.48
27
125
(3028433) Virus identified in Specimen by Culture
15
45
3.36
4.33
1.3
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
24
95
2.55
4.31
1.0
1.2
titre
290.0
140.0
—
5
18
(3021601) Nitrite [Presence] in Urine by Test strip
638
5578
1.25
4.26
5.8
4.8
estimate
0.0
0.0
0.00
146
1081
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
41
206
2.02
4.24
1.9
1.5
u/ml
240.8
131.9
—
10
42
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1025
10989
0.79
4.18
6.6
6.1
mmol/mol
40.8
40.5
0.37
941
10138
(3019977) pH of Arterial blood
21
79
2.68
4.16
4.1
3.1
ph
7.4
7.4
—
10
27
(3023487) Leukocytes [#/volume] in Peritoneal fluid
16
52
3.10
4.09
1.4
2.6
e6/l
688.8
931.3
—
6
43
(3035350) Ketones [Presence] in Urine by Test strip
639
5607
1.24
4.07
4.6
3.6
estimate
0.0
0.0
0.00
145
1063
(3004451) EKG impression Narrative
21
80
2.65
4.07
1.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
10
8.04
4.06
1.4
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
232
1.92
3.99
1.8
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
642
5649
1.24
3.95
4.6
3.6
estimate
0.0
0.0
0.32
143
1025
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
33
3.66
3.92
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
23
95
2.44
3.81
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
180
2.02
3.80
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
8
8.78
3.77
4.4
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
209
1607
1.35
3.76
1.5
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
203
1.95
3.69
4.4
3.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
54
313
1.75
3.66
1.1
1.2
titre
100.0
92.7
—
6
26
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
16
56
2.88
3.63
3.2
2.5
—
—
—
0
0
(4306422)
32
157
2.06
3.57
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
58
346
1.70
3.56
1.4
1.5
ug/g
223.5
272.3
0.99
34
209
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
7
9
7.81
3.56
1.7
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
86
2.46
3.55
2.3
2.1
e6/l
603.8
717.8
—
8
40
(3001019) Free T4 and TSH panel - Serum or Plasma
15
381
0.39
3.54
1.1
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
17
5.32
3.51
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
222
1.87
3.48
1.5
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
28
132
2.14
3.46
1.1
1.3
mosm/kgh2o
267.5
280.4
1.99
22
98
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
153
2.05
3.42
1.2
1.2
u/ml
1.6
4.9
0.96
15
53
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
47
268
1.78
3.39
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
151
1122
1.38
3.38
1.6
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
400
3391
1.24
3.37
3.8
2.9
umol/l
2761.1
6147.7
1.12
352
2925
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
134
979
1.40
3.31
5.1
2.9
ml/min/173m2
60.7
62.7
0.18
71
391
(3039443) Prostate specific Ag panel - Serum or Plasma
14
355
0.39
3.31
1.6
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
77
2.49
3.30
3.1
2.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
66
2.59
3.22
2.2
1.6
u/l
2.0
6.9
—
6
33
(3044007) Cell count panel - Peritoneal fluid
12
38
3.18
3.21
1.3
2.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
8
15
5.36
3.19
1.1
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
40
223
1.82
3.13
1.3
1.3
miu/ml
198.3
201.0
—
9
93
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
34
3.25
3.06
4.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.8
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.8
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
18
74
2.45
3.05
1.8
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
68
2.52
3.04
1.2
1.1
nmol/l
143.6
143.3
0.01
17
68
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
45
2.91
3.03
1.9
1.3
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
12
5.85
3.02
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
30
154
1.97
3.00
1.2
1.2
u/ml
2.6
6.2
1.50
16
70
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
35
3.16
2.93
1.6
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
531
1.49
2.83
3.2
3.3
pmol/l
4.2
4.5
1.42
67
471
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
31
3.24
2.77
1.5
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
73
2.34
2.65
1.5
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
73
2.34
2.65
1.5
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
236
1.71
2.63
1.4
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
49
2.67
2.62
1.5
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
61
2.47
2.62
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
14
55
2.56
2.62
1.6
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
14
55
2.56
2.62
1.6
2.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
15
4.68
2.60
1.3
1.1
%
106.9
89.3
—
7
15
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
15
4.68
2.60
1.3
1.3
umol/l
45.1
41.3
—
7
15
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
15
4.68
2.60
1.3
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
36
207
1.76
2.59
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
132
1005
1.34
2.58
5.7
3.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
14
56
2.51
2.53
1.6
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
359
3098
1.21
2.48
5.5
3.9
estimate
0.0
0.0
0.69
129
1012
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
144
1.89
2.47
1.4
1.5
%
82.0
65.4
2.36
14
97
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
442
0.54
2.46
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
39
234
1.68
2.43
1.5
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
31
174
1.80
2.43
1.1
1.1
g/l
1.7
1.5
0.97
26
160
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
153
1.85
2.39
1.2
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
50
322
1.57
2.37
1.1
1.2
—
1440.0
—
0
8
(3036603) Volume of Urine
17
78
2.19
2.31
1.8
1.5
ml
1445.2
1832.5
—
6
19
(3017732) Neutrophils [#/volume] in Blood
102
761
1.36
2.29
6.0
3.0
e9/l
4.7
4.2
0.84
76
586
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
14
59
2.39
2.29
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
14
59
2.39
2.29
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
11
41
2.70
2.28
6.0
5.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
392
0.53
2.27
1.9
1.7
mg/l
2.9
3.8
0.24
14
289
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
41
255
1.62
2.25
1.3
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
23
121
1.91
2.21
2.1
2.0
—
1.8
—
0
7
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
703
6475
1.16
2.18
3.2
2.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
447
3981
1.17
2.13
3.7
3.2
mmol/l
7.1
8.0
4.30
380
3315
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
213
1.66
2.11
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
207
1722
1.23
2.06
1.2
1.2
iu/ml
38.9
35.5
0.13
51
533
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
85
628
1.37
2.06
2.5
2.4
—
—
—
0
0
(3016750) Collection duration of Urine
17
83
2.06
2.01
2.5
2.1
min
502.0
491.0
0.08
11
53
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
51
344
1.50
2.01
1.6
1.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
11
4.56
1.94
1.8
3.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
11
4.56
1.94
4.0
2.5
u/field
0.4
0.4
—
5
11
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
33
2.74
1.93
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
33
2.74
1.93
7.4
8.0
—
—
—
0
0
(4268621)
20
107
1.88
1.86
2.2
2.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
23
3.05
1.80
1.3
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
23
3.05
1.80
1.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
192
1.63
1.78
1.5
1.2
u/ml
13.6
2.5
—
6
13
(4094501)
19
336
0.56
1.77
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
35
225
1.57
1.74
1.4
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
110
1.83
1.73
1.1
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
78
587
1.35
1.72
1.4
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
30
2.68
1.72
1.5
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
30
2.68
1.72
1.9
1.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
210
1.58
1.71
1.4
1.2
u/ml
334.6
289.1
0.33
20
122
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
61
2.14
1.71
1.8
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
720
1.31
1.70
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
25
2.81
1.65
1.0
1.2
—
—
—
0
0
(4015189)
11
49
2.25
1.63
3.5
1.8
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
36
237
1.53
1.63
1.3
1.3
u/l
53.7
47.5
0.10
26
203
(1002224) Polysomnography panel
30
460
0.65
1.60
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
14
70
2.01
1.59
2.2
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
57
2.11
1.55
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
46
323
1.44
1.54
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
323
1.44
1.54
1.4
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1087
10451
1.14
1.54
40.2
16.8
%
36.9
40.2
21.18
710
7164
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
33
2.43
1.54
1.9
2.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
18
100
1.81
1.53
2.6
2.0
u/field
1.6
1.9
—
9
39
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
244
2126
1.18
1.52
1.3
1.2
u/ml
3.1
1.5
0.39
54
569
(3026250) Tacrolimus [Mass/volume] in Blood
12
58
2.08
1.49
36.6
33.5
ug/l
7.2
7.2
0.03
12
51
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
72
1.95
1.49
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
46
326
1.42
1.48
1.4
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
110
1.74
1.43
3.0
2.2
ml
738.5
653.3
0.34
13
65
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
48
347
1.40
1.40
1.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
111
1.72
1.39
1.4
1.3
%
19.7
25.3
—
9
73
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
67
1.95
1.38
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
41
2.20
1.37
2.7
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
280
2490
1.15
1.35
5.6
3.9
kg/l
1.0
1.0
0.27
41
349
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
61
1.97
1.33
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1251
12184
1.15
1.32
43.8
18.7
mmol/l
138.3
139.7
48.25
1230
11873
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
121
1.66
1.31
1.7
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
24
2.51
1.30
5.3
9.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
24
2.51
1.30
2.5
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
37
260
1.43
1.28
1.6
1.2
u/ml
14.8
5.6
—
6
9
(3044242) Glucose [Moles/volume] in Arterial blood
15
84
1.79
1.27
3.5
2.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
84
1.79
1.27
1.8
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
44
2.05
1.27
4.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
44
2.05
1.27
4.0
2.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
6
25
2.41
1.24
1.2
1.9
pmol/l
14.2
13.6
—
6
18
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
70
1.86
1.24
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
70
1.86
1.24
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
70
1.86
1.24
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
85
1.77
1.23
2.0
2.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
129
1522
0.83
1.20
14.2
7.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
35
247
1.43
1.19
1.6
1.2
u/ml
2.5
5.2
—
9
35
(4281824)
15
86
1.75
1.19
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
12
64
1.88
1.18
9.4
17.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
43
317
1.37
1.15
1.6
1.6
e6/l
21817.2
17717.3
0.28
30
229
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
39
2.06
1.15
7.9
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
340
3096
1.13
1.15
1.4
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
415
3827
1.12
1.13
3.7
3.3
mg/l
1083.9
246.1
1.86
306
2564
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
31
2.26
1.10
1.4
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1251
12222
1.13
1.10
43.5
18.9
mmol/l
4.0
4.0
0.02
1229
11894
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
34
244
1.40
1.08
1.6
1.2
u/ml
21.4
4.2
—
7
23
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
32
2.19
1.08
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
32
2.19
1.08
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
89
1.69
1.07
1.6
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
164
1428
1.17
1.07
1.4
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
27
186
1.46
1.06
1.7
1.2
u/ml
14.4
36.0
—
5
13
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
137
1.54
1.06
1.2
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
60
473
1.28
1.04
3.0
3.3
g/l
0.6
0.3
1.10
43
194
(3014051) Protein [Presence] in Urine by Test strip
16
252
0.63
1.04
4.5
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1266
12911
0.88
1.03
53.4
23.1
e9/l
8.2
6.8
16.39
1231
12503
(3000963) Hemoglobin [Mass/volume] in Blood
1266
12909
0.88
1.01
53.7
23.2
g/l
124.1
136.8
112.48
1249
12684
(3026361) Erythrocytes [#/volume] in Blood
1266
12907
0.89
1.00
53.3
23.0
e12/l
4.2
4.5
66.74
1231
12499
(3035941) MCH [Entitic mass]
1266
12906
0.89
1.00
53.0
22.9
pg
30.1
30.5
10.77
1247
12680
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
287
2611
1.12
0.99
1.9
1.7
pmol/l
43983885.1
24266474.7
0.18
241
2180
(3024731) MCV [Entitic volume]
1266
12905
0.89
0.99
53.1
23.0
fl
91.5
91.4
0.32
1247
12681
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
309
1.34
0.99
3.0
1.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
49
1.84
0.98
1.6
2.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
31
423
0.73
0.98
1.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
61
487
1.26
0.97
1.6
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1266
12902
0.89
0.97
53.4
23.0
e9/l
274.7
238.7
31.82
1232
12540
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
18
116
1.56
0.96
1.2
1.2
nmol/l
1.5
1.4
0.18
18
104
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
41
311
1.33
0.95
1.4
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
14
85
1.65
0.94
1.3
1.9
mmol/l
7.5
7.0
—
9
49
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
55
1.82
0.92
2.9
2.9
u/l
183.2
210.9
—
10
55
(3000330) Specific gravity of Urine by Test strip
47
593
0.79
0.87
4.5
3.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
30
2.00
0.87
5.8
8.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
11
64
1.72
0.86
2.0
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
319
0.72
0.83
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
32
1.88
0.82
1.3
1.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
76
639
1.20
0.79
2.4
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
120
1050
1.16
0.78
3.6
3.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
132
1.44
0.76
2.4
2.2
u/l
4625.6
2528.1
—
5
45
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
9
53
1.70
0.75
1.1
1.1
—
391.9
—
0
13
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
67
1.65
0.75
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
31
237
1.31
0.72
2.5
2.0
—
—
—
0
0
(4133840)
5
25
2.00
0.72
1.2
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
19
134
1.42
0.71
4.6
3.2
nmol/l
30.3
5.3
0.60
19
134
(40768441) Liver Pathology biopsy report
13
85
1.53
0.69
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
29
222
1.31
0.68
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
18
127
1.42
0.68
1.2
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
28
1.79
0.66
1.8
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
128
1.41
0.65
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
12
78
1.54
0.65
1.3
1.1
—
59.9
—
0
8
(3004716) Salmonella sp identified in Stool by Organism specific culture
56
470
1.20
0.63
1.6
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
287
3069
0.92
0.62
1.8
1.7
mmol/l
1.5
1.4
0.44
248
2534
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
30
1.67
0.61
1.0
1.3
—
—
—
0
0
(4034850)
30
379
0.79
0.61
20.2
10.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
50
1.60
0.61
1.5
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
50
1.60
0.61
1.5
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
152
0.66
0.61
2.8
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
20
0.00
0.60
0.0
5.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
20
0.00
0.60
0.0
2.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
122
1.40
0.60
1.5
1.3
e6/l
323990.5
162738.7
0.21
11
83
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
148
1.36
0.59
1.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
37
300
1.24
0.58
2.7
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
485
0.82
0.58
2.7
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
82
718
1.15
0.57
4.3
3.0
e6/l
0.7
0.3
0.61
82
702
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
141
1.35
0.56
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
150
1.34
0.56
1.3
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
66
571
1.16
0.54
1.8
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
38
1.58
0.54
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
159
0.69
0.54
2.3
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
96
0.62
0.52
2.7
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
135
0.66
0.51
2.1
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
145
0.69
0.50
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
712
0.87
0.50
1.3
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
41
1.47
0.50
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
110
1.37
0.48
1.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
172
1.28
0.48
3.0
2.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
76
1.45
0.48
1.2
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
76
1.45
0.48
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
838
8185
1.05
0.45
4.0
3.5
pmol/l
14.8
14.9
0.38
764
7339
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
453
4353
1.06
0.45
5.2
3.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
283
1.21
0.45
1.5
1.4
u/l
12.0
7.9
0.64
29
229
(3041096) Erythrocytes [Presence] in Urine by Automated
319
3036
1.06
0.44
4.6
3.4
—
—
—
0
0
(3013512) EKG study
383
3668
1.06
0.43
4.6
4.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
37
436
0.84
0.43
1.6
1.8
nmol/l
45.1
39.0
0.62
37
413
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
113
1.33
0.42
2.0
2.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
6
91
0.66
0.42
2.0
2.2
ug/l
2.0
1.9
—
6
78
(3026470) Cobalt [Mass/volume] in Blood
6
94
0.64
0.42
1.7
2.1
ug/l
2.0
3.2
—
6
82
(4024509)
6
95
0.63
0.42
2.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
19
149
1.28
0.42
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
19
149
1.28
0.42
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
19
149
1.28
0.42
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
19
149
1.28
0.42
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
105
1.34
0.41
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
27.8
—
0
17
(3020650) Glucose [Presence] in Urine
5
34
1.47
0.40
1.2
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
60
1.34
0.40
2.4
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
19
150
1.27
0.40
1.3
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
107
1166
0.91
0.39
1.6
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
33
280
1.18
0.37
4.3
3.4
mmol/l
8.7
7.6
1.10
33
275
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
70
1.29
0.36
2.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
60
669
0.89
0.35
1.3
1.3
—
65.7
—
0
26
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
794
0.90
0.35
1.7
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
44
1.37
0.34
1.5
2.0
ug/l
17.7
201.3
—
6
38
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
254
0.82
0.34
1.8
1.3
e6/l
3654.3
895.0
0.81
15
211
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
254
0.82
0.34
1.8
1.3
e6/l
45.6
39.4
0.07
15
204
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
6
45
1.33
0.33
5.5
6.5
%
63.3
71.6
—
6
37
(3016018) Differential panel - Cerebral spinal fluid
15
118
1.27
0.33
1.8
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
175
1655
1.06
0.32
1.2
1.2
u/ml
28.9
12.7
0.80
39
634
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
53
1.32
0.31
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
416
4034
1.04
0.30
4.4
4.1
mg/mmol
18.5
9.1
2.17
295
2668
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
68
743
0.91
0.29
2.3
2.4
—
21.3
—
0
26
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
139
1.23
0.29
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
130
1.23
0.28
1.0
1.1
u/ml
1.4
2.0
—
8
51
(3003327) Ova and parasites identified in Stool by Light microscopy
34
298
1.14
0.28
1.3
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
40
355
1.13
0.28
2.9
2.3
ug/min
290.5
114.5
0.83
20
216
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
73
671
1.09
0.28
2.0
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
214
1.17
0.28
2.0
1.8
iu/l
3.3
5.7
—
8
66
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
74
0.67
0.26
1.0
1.8
nmol/l
13.2
18.8
—
5
65
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
197
1.17
0.26
1.7
1.6
—
—
—
0
0
(3012565) Volume of 24 hour Urine
9
72
1.25
0.25
3.1
2.7
ml
1186.7
1916.7
—
9
63
(3022145) Colonoscopy Study observation
123
1302
0.94
0.25
1.4
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
31
273
1.14
0.25
8.7
3.8
mg/l
37.3
29.1
0.41
21
179
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
75
1.20
0.25
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
75
1.20
0.25
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
115
1.22
0.23
1.0
1.0
u/ml
22.9
7.2
—
9
56
(3024471) HLA-A [Type]
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
106
1.23
0.23
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
88
1.25
0.22
1.5
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
80
748
1.07
0.22
2.0
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
110
1162
0.94
0.22
2.1
2.4
ug/g
210.0
160.8
0.46
91
937
(3048879) Bone marrow aspiration report
5
42
1.19
0.21
1.2
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
8
102
0.78
0.21
1.1
1.2
nmol/l
358.6
358.4
—
8
84
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
8.6
—
0.4
—
0
13
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
744.7
—
0
7
(21491868) Cryoglobulin [Mass/volume] in Serum
6
51
1.18
0.19
1.0
1.2
—
0.1
—
0
5
(3045142) Bone marrow Pathology biopsy report
17
146
1.17
0.19
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
109
1.19
0.18
1.0
1.1
u/ml
4.5
2.4
—
7
43
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
363
0.91
0.18
1.8
1.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
17
147
1.16
0.18
1.2
1.1
—
11.7
—
0
5
(44813793)
7
60
1.17
0.17
1.1
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1216
12084
1.03
0.17
33.9
15.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
80
1.13
0.15
3.7
2.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
121
1.16
0.15
1.4
1.3
nmol/l
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
83
1.08
0.14
1.1
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
7
86
0.81
0.14
2.0
2.3
—
181.1
—
0
17
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
97
0.82
0.13
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
117
1212
0.96
0.13
6.1
4.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
70
668
1.05
0.12
1.1
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1106
11000
1.02
0.12
31.8
14.8
ml/min/173m2
79.4
78.1
0.94
979
9178
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
124
1.13
0.11
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
251
1.08
0.10
1.4
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
71
738
0.96
0.10
4.2
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
135
1.11
0.09
1.2
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
46
1.09
0.09
1.8
2.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
47
1.06
0.09
3.8
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
31
329
0.94
0.09
4.1
4.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
61
0.82
0.08
1.4
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
61
0.82
0.08
1.4
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
63
0.79
0.08
1.4
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
164
0.91
0.08
1.5
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1242
12457
0.98
0.08
40.5
18.6
umol/l
88.4
84.8
1.26
1242
12448
(3024263) Appearance of Synovial fluid
6
72
0.83
0.07
1.5
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
76
1.05
0.07
1.1
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
127
1297
0.98
0.07
2.2
2.3
nmol/l
12.0
13.2
0.84
110
1134
(3044290) Cell count panel - Cerebral spinal fluid
25
235
1.06
0.07
1.7
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
82
0.85
0.07
1.1
1.0
mg/l
332.4
299.1
—
7
75
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
84
0.83
0.07
1.1
1.1
mg/l
43.1
45.9
—
7
72
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1237
12403
0.99
0.06
18.3
10.7
u/l
28.3
27.7
0.14
1208
11962
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
111
0.90
0.06
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
257
1.05
0.05
1.2
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
28
267
1.05
0.05
2.7
1.6
nmol/l
1.0
0.8
0.35
23
224
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1028
10253
1.01
0.04
4.9
4.2
mu/l
2.0
2.1
0.57
947
9264
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
557
1.02
0.04
1.1
1.2
iu/ml
113.2
147.7
0.18
17
215
(3003338) MCHC [Mass/volume]
971
9693
1.00
0.02
48.9
20.3
g/l
328.3
333.1
41.85
962
9605
(3023410) Appearance of Cerebral spinal fluid
12
113
1.06
0.02
2.3
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
133
1.05
0.01
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
124
1.05
0.00
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
154
0.97
0.00
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
154
0.97
0.00
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
189
1.01
0.00
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
24
235
1.02
0.00
1.5
1.4
iu/l
16.2
25.6
1.62
17
197
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
25.2
—
0
7
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
84
0.95
0.00
2.5
1.5
g/l
0.9
1.0
—
8
84
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
60
1.00
0.00
1.7
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3001729) Color of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
14
140
1.00
0.00
1.1
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
15
150
1.00
0.00
2.4
2.6
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
9
97
0.93
0.00
2.1
1.6
—
75.0
—
0
8
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
5
53
0.94
0.00
1.8
2.8
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.5
—
0
5
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
56
0.89
0.00
6.8
6.9
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
59
1.02
0.00
1.7
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.5
—
605.3
—
0
6
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_PYOTHORAX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PYOTHORAX | 4.032 [3.31, 4.91] | < 0.001 |
| Birth year | 0.997 [0.99, 1.0] | 0.41 |
During the follow-up period (1.1.1998 — 31.12.2019), 849 out of 2351 females with J10_PYOTHORAX died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_PYOTHORAX | 3.84 [3.31, 4.46] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 2609 out of 6157 males with J10_PYOTHORAX died.
Mortality risk
Mortality risk for people of age
years, who have J10_PYOTHORAX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.404% | 0.883% |
| 5 | 2.062% | 4.708% |
| 10 | 5.766% | 11.005% |
| 15 | 10.873% | 20.134% |
| 20 | 18.61% | 31.389% |
Relationships between endpoints
↥Index endpoint: J10_PYOTHORAX – Pyothorax
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data